Menu Search
Equities

Health and Happiness (H&H) International Holdings Ltd

8BI:DUS

Health and Happiness (H&H) International Holdings Ltd

Actions
  • Price (EUR)1.08
  • Today's Change-0.01 / -0.92%
  • Shares traded800.00
  • 1 Year change-16.28%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2024 18:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Health and Happiness (H&H) International Holdings Limited, formerly Biostime International Holdings Ltd., is an investment holding company principally engaged in the manufacture and sale of premium pediatric nutritional. The Company operates through five business segments. The Infant Formulas segment is engaged in the production of infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. The Adult Nutrition and Care Products segment is engaged in the production of vitamins, health supplements, skin care and sports nutrition products for adults. The Probiotic Supplements segment is engaged in the production of probiotic supplements. The Dried Baby Food and Nutrition Supplements segment is engaged in the production of dried baby food products made from natural foods, as well as microencapsulated milk calcium chewable tablets. The Baby Care Products segment is engaged in the production of baby care products.

  • Revenue in HKD (TTM)14.67bn
  • Net income in HKD300.72m
  • Incorporated2010
  • Employees3.17k
  • Location
    Health and Happiness (H&H) International Holdings LtdSuites 4007-0940/F, One Island East, Taikoo Place, 18 Hong KongHKG
  • Websitehttp://www.hh.global
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.